Introduction and Importance: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the source of COVID-19, a respiratory disease. It typically manifests as restricted pulmonary symptoms, but autoimmune dysfunction might occasionally show up. A COVID-19 infection may cause a multi-system connective tissue disease known as systemic sclerosis (SSc). In patients who recovered from COVID-19, autoimmunity may have multiple underlying causes. Case Presentation: We report the case of a 68-year-old female who, one month after contracting COVID-19, complained of dyspnea and muscle exhaustion. The patient was treated for post-COVID syndrome. She developed symptoms of chronic dyspnea, pale fingers, pursed lips, trouble chewing and swallowing, and muscle weakness after seven weeks. A chest HRCT (High-Resolution Computerised Tomography) scan suggested interstitial lung disease. Clinical characteristics and an autoantibody profile containing anti-Ro 52 and anti-centromere antibodies pointed towards systemic sclerosis. She was treated with azathioprine and prednisolone at a reduced dosage, and she is now stable with monthly follow-ups. Clinical Discussion: COVID-19 might induce cytokine storms and immunological dysregulation, ultimately culminating in autoimmune manifestations. Several autoantibodies are observed in autoimmune illnesses in post-COVID-19 infection patients. Our situation is distinct because systemic sclerosis following a COVID-19 infection is not commonly seen as an autoimmune illness. Conclusion: The number of patients with rare autoimmune diseases, like systemic sclerosis, following COVID-19 has been rising. Therefore, we should consider the possibility of autoimmune disease when looking into a patient who presents strangely or has developed new symptoms after COVID and should contact the patient’s management immediately.
No takes yet. Share an insight, caveat, or question.
Oli et al. (2024) studied this question.